Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis

Fig. 1

Validation of chemokine expression in the peripheral blood of patients with TAK. A Higher levels of CCL22 (a), RANTES (b), CXCL16 (c), CXCL11 (d), and IL-16 (e) were observed in TAK patients in contrast to the healthy controls (n = 20 in each group). B No differences were found in CCL1 (a), XCL1 (b), CX3CL1 (c), CXCL1 (d), CCL17 (e), CCL19 (f), and CCL20 (g) levels between patients with TAK and the controls (n = 20 in each group). C Higher levels of CCL22 (a), RANTES (b), CXCL16 (c), CXCL11 (d), IL-16 (e), IL-6 (f), and IL-17 (g) were confirmed in patients with TAK than in the controls (n = 25 in each group). *p < 0.05, ****p < 0.0001, ns = not significant

Back to article page